RedHill Biopharma (RDHL) News Today $0.40 +0.02 (+5.31%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 25 at 1:07 PM | bizjournals.comRaleigh pharma gets cash jolt at critical timeJuly 24 at 10:51 AM | americanbankingnews.comRedHill Biopharma (NASDAQ:RDHL) Receives New Coverage from Analysts at StockNews.comJuly 22, 2024 | prnewswire.comRedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® LienJuly 9, 2024 | prnewswire.comRedHill Biopharma Terminates License Agreement for Aemcolo®June 3, 2024 | prnewswire.comRedHill Announces a New Patent Covering Opaganib in Combination with Immune Checkpoint Inhibitors, Valid Through 2040May 22, 2024 | uk.finance.yahoo.comPensioners win £9,000 back in 16-year council tax battleMay 7, 2024 | finanznachrichten.deRedHill Biopharma Ltd.: RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035May 6, 2024 | prnewswire.comRedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035April 24, 2024 | finance.yahoo.comRedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 StudyApril 10, 2024 | finance.yahoo.comRedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (vs US$46.29 loss in FY 2022)April 9, 2024 | bizjournals.comRaleigh pharma weighs divesting commercial operationsApril 8, 2024 | finanznachrichten.deRedHill Biopharma Ltd.: RedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsApril 8, 2024 | finance.yahoo.comRedHill Biopharma Ltd. (2RH0.F)April 8, 2024 | prnewswire.comRedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsApril 2, 2024 | finance.yahoo.comRedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market PriceMarch 11, 2024 | markets.businessinsider.comRedHill Biopharma Receives New Patent For H. Pylori Treatment TaliciaMarch 11, 2024 | finance.yahoo.comRedHill Announces New USPTO Patent Covering Talicia® Through 2034March 5, 2024 | finance.yahoo.comRedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures ProgramsFebruary 20, 2024 | finance.yahoo.comRedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New PublicationFebruary 20, 2024 | prnewswire.comRedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New PublicationFebruary 16, 2024 | barrons.comRedHill Biopharma Ltd. ADRJanuary 26, 2024 | finance.yahoo.comRedHill Biopharma Announces Closing of $8 Million Registered Direct OfferingJanuary 25, 2024 | msn.comRedHill gains after new patent grant for Talicia for H. pylori treatment through 2042January 25, 2024 | finance.yahoo.comRedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042January 25, 2024 | finance.yahoo.comRedHill Biopharma Announces $8 Million Registered Direct OfferingJanuary 24, 2024 | benzinga.comWhy Redhill Biopharma Stock Is Moving HigherDecember 20, 2023 | msn.comRedHill's Investigational COVID-19 Drugs Combined With Gilead's Show Effect Against EbolaDecember 20, 2023 | markets.businessinsider.comRedHill Announces Results Of A New U.S. Army-funded In Vivo Ebola Virus StudyDecember 20, 2023 | msn.comRedHill shares rally 20% on positive data for two antiviral drugsDecember 20, 2023 | finance.yahoo.comRedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against EbolaDecember 12, 2023 | msn.comRedHill Biopharma regains compliance with Nasdaq listing ruleDecember 4, 2023 | finance.yahoo.comRedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 StudyNovember 30, 2023 | benzinga.comRedhill Biopharma Stock (NASDAQ:RDHL), Short Interest ReportNovember 29, 2023 | msn.comWhat's Going On With Redhill Biopharma Stock?November 29, 2023 | marketbeat.comTrading was temporarily halted for "RDHL" at 10:11 AM with a stated reason of "LULD pause."November 28, 2023 | marketbeat.comTrading was temporarily halted for "RDHL" at 10:11 AM with a stated reason of "LULD pause."November 28, 2023 | marketbeat.comTrading was temporarily halted for "RDHL" at 09:11 AM with a stated reason of "LULD pause."November 27, 2023 | investorplace.com5 Investors Betting Big on RedHill Biopharma (RDHL) StockNovember 27, 2023 | msn.comWhy Is Gastrointestinal Disease Focused-RedHill Biopharma Stock Higher Over 100% Today?November 27, 2023 | markets.businessinsider.comRedHill's Talicia Granted 5-year Market Exclusivity By FDANovember 27, 2023 | finance.yahoo.comRedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034November 22, 2023 | finance.yahoo.comRedHill Biopharma Announces the Transfer of its Listing to The Nasdaq Capital MarketOctober 19, 2023 | benzinga.comThe Street Reports: Guide to Penny Stocks Look Now! CLNV, ARAV, RDHL, ATHX, EPAZOctober 3, 2023 | msn.comIsrael-Based Penny Stock RedHill Biopharma Is Trading Higher Today - Here's Why?October 3, 2023 | finance.yahoo.comRedHill and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo StudySeptember 5, 2023 | finance.yahoo.comRedHill Announces New USPTO Notice of Patent Allowance for Opaganib and EU Patent Grant for RHB-102 (BEKINDA®)August 17, 2023 | finance.yahoo.comRedHill Biopharma Provides H1/23 Financial Results and Operational HighlightsJuly 31, 2023 | finance.yahoo.comRedHill's RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial and Cleared for Initiation by FDAJuly 25, 2023 | finance.yahoo.comRedHill Biopharma Announces Closing of $3.8 Million Registered Direct Offering and Warrant ExerciseJuly 21, 2023 | benzinga.comWhat's Going On With RedHill Biopharma Stock Today Get RedHill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here RDHL Media Mentions By Week RDHL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDHL News Sentiment▼0.370.61▲Average Medical News Sentiment RDHL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDHL Articles This Week▼50▲RDHL Articles Average Week Get RedHill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ProMIS Neurosciences News Today IN8bio News Today Cue Biopharma News Today Natural Alternatives International News Today Lipocine News Today LianBio News Today ImmuCell News Today Pluri News Today VYNE Therapeutics News Today NKGen Biotech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RDHL) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share RedHill Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
